<DOC>
	<DOCNO>NCT00860730</DOCNO>
	<brief_summary>The clinical investigation design prospective non-randomised study maximum 150 patient . This study conduct Investigational Centres European Community . A minimum number 8 European Centres involve clinical investigation . A minimum 15 patient enrol Investigational Centre . The clinical follow-up require evaluation discharge ( 30 day patient still hospitalize ) , 3-6 12 month follow procedure.The primary objective clinical investigation ass performance Perceval S valve 3-6 month implantation high surgical risk patient , require surgical intervention replace aortic valve .</brief_summary>
	<brief_title>PERCEVAL Pivotal Trial</brief_title>
	<detailed_description>The design Perceval S prosthesis stem intention offer alternative traditional flexible prosthesis ( stented stentless biological valve ) use conventional open-heart surgery . As result sutureless implant procedure , fact , patient could benefit : Reducing aortic clamp time , subsequent overall reduction surgical timing therefore reduction related risk ; Avoiding pas stitch annulus suture knot , consequent less risk tear aortic annulus wall , damage bundle His , embolizing foreign material vascular system .</detailed_description>
	<criteria>Subjects 75 year old ; Subjects aortic valve stenosis stenoinsufficiency ; Subjects high surgical risk candidate aortic valve replacement biological prosthesis ; Subjects NYHA functional class III IV Logistic EuroSCORE great 5 % . Subjects agree participation clinical evaluation sign informed consent ; Subjects willing undergo medical followup echocardiographic examination laboratory test form part present protocol . Subjects involve clinical study drug device ; Subjects previously undergone implantation Perceval S prosthesis assess ; Subjects previous implantation valve prostheses annuloplasty ring mitral position ; Subjects require simultaneous procedure , apart septal myectomy and/or coronary bypass ; Subjects aneurysmal dilation dissection ascend aortic wall need surgical correction ; Subjects need non elective intervention ; Subjects aortic annulus ( procedure decalcification ) dimension implantation valve size 21 23 mm possible ( direct intraoperative measurement sizer ) , accordance indication report Investigator 's Brochure ; Subjects active endocarditis ; Subjects active myocarditis ; Subjects anomaly coronary ostia determine preoperative coronary angiogram intervention ; Subjects congenital bicuspid aortic valve ; Subjects aortic root enlargement , ratio observe expected diameter ( calculate function age patient body surface area ) &gt; 1.3 ; Subjects aortic root enlargement , ratio diameter sinotubular junction annulus diameter &gt; 1.3 ; Subjects myocardial infarct &lt; =90 day ; Subjects know hypersensitivity nickel alloy .</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Aortic valve replacement</keyword>
	<keyword>Aortic stenosis</keyword>
	<keyword>Biological valve</keyword>
	<keyword>Sutureless valve</keyword>
	<keyword>Stented valve</keyword>
	<keyword>Aortic Valve Disease</keyword>
</DOC>